methoxyhydroxyphenylglycol has been researched along with hexanoylcarnitine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, F; Albillos, A; Alessandria, C; Angeli, P; Arroyo, V; Bañares, R; Berg, T; Bernardi, M; Bruns, T; Caraceni, P; Castelli, FA; Claria, J; de la Peña-Ramirez, C; Diaz, JM; Domenicali, M; Fenaille, F; Fernández, J; Gambino, CG; Genesca, J; Gerbes, AL; Giovo, I; Gu, W; Gustot, T; Jalan, R; Jansen, C; Jiménez, C; Junot, C; Laleman, W; Lozano, JJ; Martin, PI; Merli, M; Mookerjee, R; Moreau, R; Papp, M; Piano, S; Presa, J; Putignano, A; Saliba, F; Sánchez-Garrido, C; Sierra, P; Trautwein, C; Trebicka, J; Uschner, FE; Vargas, V; Weiss, E; Wendon, JA; Zaccherini, G; Zeuzem, S; Zipprich, A | 1 |
1 other study(ies) available for methoxyhydroxyphenylglycol and hexanoylcarnitine
| Article | Year |
|---|---|
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Topics: Acute-On-Chronic Liver Failure; Humans; Inflammation; Liver Cirrhosis; Metabolomics; Methoxyhydroxyphenylglycol; Mitochondria; Prognosis; Prospective Studies | 2023 |